Saludar, Virgel A.
HRN: 24-78-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2024
CEFTRIAXONE 1G (VIAL)
04/13/2024
04/20/2024
IV
2g
Every 12 Hours
Blunt Thoracic Injury Secondary To MVA, S/P CTT Insertion
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes